Abstract
The spleen is the largest lymphoid tissue in the human body and is composed of red and white pulp along with the supporting stroma. It is an important organ for filtration, immune regulation, and hematopoiesis during fetal development. Although the intact immune modulation from the spleen would protect human beings from diseases, there are a number of primary and secondary hematologic malignancies that may occur when immunity of the spleen is compromised or overridden by other processes. Additional non-hematopoietic diseases affecting the spleen include, but are not limited to, viral, bacterial, fungal, and parasitic infections, sarcoidosis, and storage disorders; these diseases may sometimes mimic primary hematologic neoplasms. The chapter will focus on conventional diagnostic approaches to hematologic disorders of the liver and spleen, mainly including gross and microscopic examination and immunophenotyping. Biopsy indications and histology processes have also been discussed.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–16.
Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806–18.
Corless JK, Middleton HM 3rd. Normal liver function. A basis for understanding hepatic disease. Arch Intern Med. 1983;143(12):2291–4.
Torbenson M, Zen Y, Yeh M. Tumors of the liver. Washington, D.C.: ARP Press; 2018.
Hiatt J, Phillips E, Morgenstern L. Surgical diseases of the spleen. Heidelberg: Springer; 1997.
Johnson HA, Deterling RA. Massive splenomegaly. Surg Gynecol Obstet. 1989;168(2):131–7.
Lehne G, Hannisdal E, Langholm R, Nome O. A 10-year experience with splenectomy in patients with malignant non-Hodgkin’s lymphoma at the Norwegian Radium Hospital. Cancer. 1994;74(3):933–9.
Lv Y, Lau WY, Li Y, et al. Hypersplenism: history and current status. Exp Ther Med. 2016;12(4):2377–82.
Cadili A, de Gara C. Complications of splenectomy. Am J Med. 2008;121(5):371–5.
Machado NO, Grant CS, Alkindi S, et al. Splenectomy for haematological disorders: a single center study in 150 patients from Oman. Int J Surg. 2009;7(5):476–81.
Dendle C, Sundararajan V, Spelman T, Jolley D, Woolley I. Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria. Med J Aust. 2012;196(9):582–6.
Alzen G, Basedow J, Luedemann M, Berthold LD, Zimmer KP. Partial splenic embolization as an alternative to splenectomy in hypersplenism–single center experience in 16 years. Klin Padiatr. 2010;222(6):368–73.
Amin MA, el-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–10.
George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3–40.
Kappers-Klunne MC, Wijermans P, Fijnheer R, et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol. 2005;130(5):768–76.
Bonnet S, Guedon A, Ribeil JA, Suarez F, Tamburini J, Gaujoux S. Indications and outcome of splenectomy in hematologic disease. J Visc Surg. 2017;154(6):421–9.
Katz SC, Pachter HL. Indications for splenectomy. Am Surg. 2006;72(7):565–80.
Singh AK, Shankar S, Gervais DA, Hahn PF, Mueller PR. Image-guided percutaneous splenic interventions. Radiographics. 2012;32(2):523–34.
Patel N, Dawe G, Tung K. Ultrasound-guided percutaneous splenic biopsy using an 18-G core biopsy needle: our experience with 52 cases. Br J Radiol. 2015;88(1055):20150400.
Libepathology.org/wiki/splenectomy-grossing. In: Patholog L, ed 2019.
Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004;24(4):1137–63.
O’Malley DP, George T, Orazi A, Abbondanzo S. Benign and reactive conditions of lymph node and spleen, vol. 7. Washington, D.C.: American Registery of Pathology; 2009.
Lester. Manual of surgical pathology. Philadelphia: Churchill Livingstone; 2001.
Wotherspoon A, Attygalle A, Mendes LS. Bone marrow and splenic histology in hairy cell leukaemia. Best Pract Res Clin Haematol. 2015;28(4):200–7.
Urrutia M, Mergo PJ, Ros LH, Torres GM, Ros PR. Cystic masses of the spleen: radiologic-pathologic correlation. Radiographics. 1996;16(1):107–29.
Morgenstern L. Nonparasitic splenic cysts: pathogenesis, classification, and treatment. J Am Coll Surg. 2002;194(3):306–14.
McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology. 2011;260(3):699–708.
Keogan MT, Freed KS, Paulson EK, Nelson RC, Dodd LG. Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness. AJR Am J Roentgenol. 1999;172(4):933–7.
Civardi G, Vallisa D, Berte R, et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol. 2001;67(2):93–9.
Tam A, Krishnamurthy S, Pillsbury EP, et al. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol. 2008;19(1):80–7.
Friedlander MA, Wei XJ, Iyengar P, Moreira AL. Diagnostic pitfalls in fine needle aspiration biopsy of the spleen. Diagn Cytopathol. 2008;36(2):69–75.
Ramdall RB, Cai G, Alasio TM, Levine P. Fine-needle aspiration biopsy for the primary diagnosis of lymphoproliferative disorders involving the spleen: one institution’s experience and review of the literature. Diagn Cytopathol. 2006;34(12):812–7.
Gomez-Rubio M, Lopez-Cano A, Rendon P, et al. Safety and diagnostic accuracy of percutaneous ultrasound-guided biopsy of the spleen: a multicenter study. J Clin Ultrasound. 2009;37(8):445–50.
Phillips EH, Carroll BJ, Fallas MJ. Laparoscopic splenectomy. Surg Endosc. 1994;8(8):931–3.
Poulin EC, Thibault C, Mamazza J. Laparoscopic splenectomy. Surg Endosc. 1995;9(2):172–6; discussion 176–7
Bonds LA, Barnes P, Foucar K, Sever CE. Acetic acid-zinc-formalin: a safe alternative to B-5 fixative. Am J Clin Pathol. 2005;124(2):205–11.
Medeiros L, O’Malley DP, Caraway N, Vega F, Elenitoba-Johnson K, Lim M. Tumors of the lymph nodes and spleen. Washington, D.C.: ARP Press. 2017
Neiman RS. Incidence and importance of splenic sarcoid-like granulomas. Arch Pathol Lab Med. 1977;101(10):518–21.
Rosso R, Neiman RS, Paulli M, et al. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol. 1995;26(1):39–46.
Borch WR, Aguilera NS, Brissette MD, O'Malley DP, Auerbach A. Practical applications in immunohistochemistry: an immunophenotypic approach to the spleen. Arch Pathol Lab Med. 2019;143(9):1093–105.
Grimm K, Barry T, Omarrley D, Weiss L. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic and lymphoid neoplasms. In: Knowles’ neoplasmitc hematopathology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 1992. p. 91–118.
Sherman MJ, Hanson CA, Hoyer JD. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol. 2011;136(3):390–9.
Neiman R, Orazi A. Hematopmathologic manifestation of lymphoproliferative and myeloproliferative disorders involving the spleen. In: DM K, editor. Neoplastic hematopathology. Baltimore: Lipplincott Williams & Wilkins; 2000.
Du J, Shen Q, Yin H, Zhou X, Wu B. Littoral cell angioma of the spleen: report of three cases and literature review. Int J Clin Exp Pathol. 2015;8(7):8516–20.
Peckova K, Michal M, Hadravsky L, et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69(5):762–74.
Ujjani C, Cheson BD. The current status and future impact of targeted therapies in non-Hodgkin lymphoma. Expert Rev Hematol. 2013;6(2):191–202; quiz 203
Miliotou AN, Papadopoulou LC. CAR T-cell therapy: a new era in cancer immunotherapy. Curr Pharm Biotechnol. 2018;19(1):5–18.
Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol. 2000;24(7):1016–9.
Sharpe RW, Bethel KJ. Hairy cell leukemia: diagnostic pathology. Hematol Oncol Clin North Am. 2006;20(5):1023–49.
Foucar K, Catovsky D, et al. Hairy cell leukemia. In: Swedlow S, Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissue. Lyon: LARC; 2008. p. 188–90.
Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305–15.
Arcaini L, Zibellini S, Boveri E, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012;119(1):188–91.
Xi L, Arons E, Navarro W, et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119(14):3330–2.
Thieblemont C, Davi F, Noguera ME, et al. Splenic marginal zone lymphoma: current knowledge and future directions. Oncology (Williston Park). 2012;26(2):194–202.
Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994;14(Suppl 1):57–61.
Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D, British Committee for Standards in H. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant∗. Br J Haematol. 2012;156(2):186–95.
Mason EF, Brown RD, Szeto DP, et al. Detection of activating MAP 2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leuk Lymphoma. 2017;58(1):233–6.
Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP 2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46(1):8–10.
Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253–60.
Mendes LS, Attygalle A, Matutes E, Wotherspoon A. Annexin A1 expression in a splenic diffuse red pulp small B-cell lymphoma: report of the first case. Histopathology. 2013;63(4):590–3.
Curiel-Olmo S, Mondejar R, Almaraz C, et al. Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood. 2017;129(8):1042–5.
Colovai AI, Giatzikis C, Ho EK, et al. Flow cytometric analysis of normal and reactive spleen. Mod Pathol. 2004;17(8):918–27.
Imashuku S, Obayashi M, Hosoi G, et al. Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results. Br J Haematol. 2000;108(3):505–10.
Lucio P, Parreira A, van den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 1999;13(3):419–27.
Zeppa P, Anniciello A, Vetrani A, Palombini L. Fine needle aspiration biopsy of hepatic focal fatty change. A report of two cases. Acta Cytol. 2002;46(3):567–70.
Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part I. Procedural aspects, diagnostic adequacy, and accuracy. Radiology. 2012;265(3):819–31.
Laribi K, Lemaire P, Sandrini J, Baugier de Materre A. Advances in the understanding and management of T-cell prolymphocytic leukemia. Oncotarget. 2017;8(61):104664–86.
Tannapfel A, Dienes HP, Lohse AW. The indications for liver biopsy. Dtsch Arztebl Int. 2012;109(27–28):477–83.
Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut. 1999;45 Suppl 4:IV1–IV11.
Mastoraki A, Stefanou MI, Chatzoglou E, et al. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30(3):150–4.
Elsayes KM, Menias CO, Willatt JM, Pandya A, Wiggins M, Platt J. Primary hepatic lymphoma: imaging findings. J Med Imaging Radiat Oncol. 2009;53(4):373–9.
Gota VS, Purandare NC, Gujral S, Shah S, Nair R, Rangarajan V. Positron emission tomography / computerized tomography evaluation of primary Hodgkin’s disease of liver. Indian J Cancer. 2009;46(3):237–9.
El-Sharkawi D, Ramsay A, Cwynarski K, et al. Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. Leuk Lymphoma. 2011;52(11):2130–4.
Fu DA, Campbell-Thompson M. Periodic acid-Schiff staining with diastase. Methods Mol Biol. 2017;1639:145–9.
Agmon-Levin N, Berger I, Shtalrid M, Schlanger H, Sthoeger ZM. Primary hepatic lymphoma: a case report and review of the literature. Age Ageing. 2004;33(6):637–40.
Anthony PP, Sarsfield P, Clarke T. Primary lymphoma of the liver: clinical and pathological features of 10 patients. J Clin Pathol. 1990;43(12):1007–13.
Swerdlow S, Campo E, Harris N, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017.
Salmon JS, Thompson MA, Arildsen RC, Greer JP. Non-Hodgkin’s lymphoma involving the liver: clinical and therapeutic considerations. Clin Lymphoma Myeloma. 2006;6(4):273–80.
Zucca E, Gregorini A, Cavalli F. Management of non-Hodgkin lymphomas arising at extranodal sites. Ther Umsch. 2010;67(10):517–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zhang, L., Basra, P., Alkan, S. (2020). Diagnostic Approaches to Hematopoietic Disorders of the Spleen and Liver. In: Zhang, L., Shao, H., Alkan, S. (eds) Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver. Springer, Cham. https://doi.org/10.1007/978-3-030-37708-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-37708-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37707-6
Online ISBN: 978-3-030-37708-3
eBook Packages: MedicineMedicine (R0)